FDAは、追加接種の有効性に関するデータが不十分であることと、ワクチン接種の推奨に対する国民の信頼が低下していることを理由に、来シーズンのCOVID-19ワクチンの承認に対するアプローチを再検討している。 FDA長官のマーティ・マカリー博士は、新たな ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

The Food and Drug Administration on Tuesday named Dr. Vinay Prasad — a hematologist-oncologist who has been accused of ...

Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad to lead the agency’s Center for Biologics Evaluation and ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

The head of the U.S. Food and Drug Administration (FDA) reiterated Tuesday that the agency is applying a more skeptical ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season. Later this month, the FDA will convene its external vaccine advisors to decide on the ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...